News

The IRS has undergone major changes in the early months of the Trump administration, including cost cuts, staff cuts and what observers say are breaks with past norms on taxpayer privacy. DOGE, a ...
Tesla CEO says the EV company's sales are already improving, reaffirms 'robotaxi' service next month Tesla Inc. Chief Executive Elon Musk said he planned to cut back on his political spending and ...
The cybersecurity company also saw a growth slowdown in remaining performance obligations, a metric that measures future revenue expected from current contracts Palo Alto Networks Inc.'s in-line ...
Palo Alto Networks logged higher revenue in its fiscal third quarter, though profit slipped as expenses increased. The cybersecurity company posted adjusted earnings of 80 cents a share on sales of $2 ...
This article contemplates the past, present, and future of Latin American stocks, which have posted strong gains in 2025 but have been long-term underperformers.
BANFF, Alberta--Free and fair trade is "fundamental" to bring stability to the global economy and persuade businesses to start investing again, Canadian Finance Minister Francois-Philippe Champagne ...
Mergers and acquisitions have been central to Generation’s recent growth, with a focus on businesses it believes will benefit from regulatory or structural tailwinds. Lonsec was acquired in stages, ...
Amer Sports (AS) said its sales of its Salomon footwear continued to "grow very well" in China in its latest quarter, as did its Wilson Tennis 360 shops, as the company tapped into the "high quality ...
Dow Jones Top Company Headlines at 7 PM ET: In Latest EV Pullback, Ford to Share Battery Plant With Nissan | Kraft ... In Latest EV Pullback, Ford to Share Battery Plant With Nissan A Kentucky battery ...
U.S. stocks fell, ending a six-day winning streak for the S&P 500, as losses in Big Tech weighed on major indexes. Canada Inflation Slows to 1.7% in April as Carbon Tax Ends The headline figure, ...
The pharmaceutical company said Tuesday the FDA's Oncologic Drugs Advisory Committee voted 6-2 in favor of Darzalex Faspro, or daratumumab and hyaluronidase-fihj, to treat adult patients with ...